Clinical trials reveal significant improvements for chronic sufferers.
Tag: asthma
Dupilumab Outperforms Omalizumab in High-Biomarker Asthma Trial
At the EAACI 2026 conference, dupilumab demonstrated superior outcomes over omalizumab in patients with severe asthma characterised by high biomarker levels.